Kevin Kinsella
-
Senate Dems move to force detailed disclosure of Trump’s pharma deals
The legislation would require the Trump administration to reveal the deals it cut with pharma companies to assess whether they deliver real savings or not.
-
What the DOJ’s record-breaking 2025 enforcements say about the future
With $5.7 billion in healthcare-related recoveries, expanding interagency collaboration, and a deep pipeline of whistleblower initiated cases, the DOJ’s FCA enforcement efforts show no signs of easing through 2026.
-
UnitedHealthcare speeds up payments, slashes prior authorization for rural hospitals
The health insurance giant is using its Rural Payment Acceleration Pilot program to support more than 1,500 rural hospitals.
-
Health‑related fraud cases feature in latest DOJ enforcement actions
Healthcare-related enforcements totaled nearly $74m in just one week.
-
CMS proposes to roll back add‑on payment pathway for breakthrough devices
A proposed rule change would require breakthrough devices to meet the same evidence standards as all other new technologies, reshaping reimbursement incentives starting in 2028.
-
White House issues executive order to pave way for psychedelic drug treatments
The order, which surprised some legal analysts, will accelerate access to some Schedule I controlled substances to treat patients with serious mental illness.
-
Kennedy signals overhaul of US Preventive Services Task Force
During a heated testimony before the House Committee on Ways and Means, the HSS secretary criticized the task force for a “lackadaisical” approach over two decades.
-
FDA to consider relaxing restrictions for peptides
The regulator said it is looking to take seven peptides off a restrictive list for unapproved drugs considered too risky.